NK cell differentiation

ImmuneBridge is a biotech company building a platform that integrates source screening and scalable manufacturing to enable high quality cell therapies to be rapidly designed and manufactured at commercial scale and ultralow cost. It uses young, healthy, disease-free umbilical cord blood stem cells and an ML-powered screening system, and offers proprietary stem cell expansion technology for manufacturing HSCs, NK cells, T cells, red blood cells, neutrophils, and mitochondria.

Read more

cell engineeringcell therapy manufacturingML-powered screeningstem cell expansion